what are the Recommendations for Choice of SAVR Versus TAVI for Patients for
Whom a Bioprosthetic AVR Is Appropriate
Referenced studies that support the recommendations are
summarized in Online Data Supplement 11 to 13.?
For symptomatic patients with severe AS who are >80 years of age or for younger patients with a life expectancy <10 years and no anatomic contraindication to transfemoral TAVI, transfemoral TAVI is recommended in preference to SAVR.